Royalty Pharma Plc- Cl A
Held by 2 superinvestors (RPRX).
Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.
Ownership · 13F consensus
Who's buying it
Institutional ownership aggregated across funds — consensus strength and this quarter's moves. Describes actions, not advice.
2 superinvestors hold it · $284.0M combined
Largest holder Samantha McLemore
Held by 2 superinvestors of Royalty Pharma Plc- Cl A (RPRX); this quarter 2 added (as of 2026-03-31).
13F positions are self-reported and can lag up to 45 days. Informational only — not investment advice.
Superinvestors Holding This Security
- Value$174.8MWeight (prev→now)5.0% → 6.4% ▲
- Value$109.2MWeight (prev→now)7.6% → 8.7% ▲
Ownership overview
Royalty Pharma Plc- Cl A (RPRX) is held by 2 of the superinvestors tracked on Compounder, with a combined $284.0M in reported 13F value. The largest position belongs to Samantha McLemore, where it makes up 6.4% of the portfolio.
Other notable holders by value include Pat Dorsey (8.7% of its book).
Over the latest quarter, 0 of the tracked filers opened a new position in RPRX, 2 added to existing ones, 0 trimmed, and 0 sold out entirely.
Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-03-31. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.
Holders over time
Superinvestors holding this security over the last 8 quarters: 3 → 2.
Early quarters may understate holder counts due to data backfill — read the slope with care.
Sources· SEC EDGAR 13F as of 2026-05-15
Related
Stay Updated
Curated 13F moves and valuation insights, straight to your inbox.